Eshet R, Laron Z, Pertzelan A, Arnon R, Dintzman M. Defect of human growth hormone receptors in the liver of two patients with Laron-type dwarfism. Isr J Med Sci. 1984;20(1):8-11. https://pubmed.ncbi.nlm.nih.gov/6321400.

Berg MA, Argente J, Chernausek S, et al. Diverse growth hormone receptor gene mutations in Laron syndrome. Am J Hum Genet. 1993;52(5):998-1005. https://pubmed.ncbi.nlm.nih.gov/8488849. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1682057.

Laron Z, Pertzelan A, Mannheimer S. Genetic pituitary dwarfism with high serum concentration of growth hormone--A new inborn error of metabolism? Isr J Med Sci. 1966;2(2):152-5. https://pubmed.ncbi.nlm.nih.gov/5916640.

Laron Z. Laron syndrome (primary growth hormone resistance or insensitivity): The personal experience 1958-2003. J Clin Endocrinol Metab. 2004;89(3):1031-44. https://pubmed.ncbi.nlm.nih.gov/15001582. https://doi.org/10.1210/jc.2003-031033.

Dehiya RK, Bhartiya D, Kapadia C, Desai MP. Insulin like growth factor-I, insulin like growth factor binding protein-3 and acid-labile subunit levels in healthy children and adolescents residing in Mumbai suburbs. Indian Pediatr. 2000;37(9): 990-7. https://pubmed.ncbi.nlm.nih.gov/10992336.

Savage MO, Blum WF, Ranke MB, et al. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome). J Clin Endocrinol Metab. 1993;77(6):1465-71. https://pubmed.ncbi.nlm.nih.gov/7505286. https://doi.org/10.1210/jcem.77.6.7505286.

Chakraborty PP, Basu AK, Mandal SK, Dipanjan B. Laron′s syndrome in two siblings. Indian J Pediatr. 2007;74:870-1. https://pubmed.ncbi.nlm.nih.gov/117901683. https://doi.org/10.1007/s12098-007-0159-y.

Kornreich L, Horev G, Schwarz M, Karmazyn B, Laron Z. Pituitary size in patients with Laron Syndrome (primary GH insensitivity). Eur J Endocrinol. 2003;148(3):339-41. https://pubmed.ncbi.nlm.nih.gov/12611615. https://doi.org/10.1530/eje.0.1480339.

Merimee TJ, Hall J, Rabinowitz D, McKusick VA, Rimoin DL. An unusual variety of endocrine dwarfism: Subresponsiveness to growth hormone in a sexually mature dwarf. Lancet. 1968;2(7561):191-3. https://pubmed.ncbi.nlm.nih.gov/4173406. https://doi.org/10.1016/s0140-6736(68)92623-8.

Blum WF, Cotterill AM, Postel-Vinay MC, Ranke MB, Savage MO, Wilton P. Improvement of diagnostic criteria in growth hormone insensitivity syndrome: Solutions and pitfalls. Acta Paediatr Suppl. 1994;399:117-24. https://pubmed.ncbi.nlm.nih.gov/7949595. https://doi.org/10.1111/j.1651-2227.1994.tb13303.x.

Ranke MB, Wölfle J, Schnabel D, Bettendorf M. Treatment of dwarfism with recombinant human insulin-like growth factor-1. Dtsch Arztebl Int. 2009;106(43):703-9. https://pubmed.ncbi.nlm.nih.gov/19946434. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780013. https://doi.org/10.3238/arztebl.2009.0703

Rosenbloom AL, Guevara-Aguirre J, Rosenfeld RG, Francke U. Growth hormone receptor deficiency in Ecuador. J Clin Endocrinol Metab. 1999;84:4436-43. https://pubmed.ncbi.nlm.nih.gov/10599699. https://doi.org/10.1210/jcem.84.12.6283.

Laron Z. Laron syndrome (primary growth hormone resistance or insensitivity): The personal

experience 1958-2003. J Clin Endocrinol Metab. 2004; 89(3):1031-44. https://pubmed.ncbi.nlm.nih.gov/15001582. https://doi.org/10.1210/jc.2003-031033.